Veracyte
Latest round
- Series C
Last raised
- Jun 2013
Total raised
- $68M
Investors
- 5
About Veracyte
, operates as a developer of genomic diagnostics for thyroid and non-small cell lung cancer.
Who invested in Veracyte
5 investors across 4 rounds
See all investors in Veracyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Veracyte
Who invested in Veracyte?
Veracyte has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Veracyte raised?
Veracyte has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Veracyte last raise money?
Veracyte's most recent round on record is a Series C, in Jun 2013.
What does Veracyte do?
, operates as a developer of genomic diagnostics for thyroid and non-small cell lung cancer.
Where is Veracyte headquartered?
Veracyte is headquartered in South San Francisco, US.
Which VCs invest in companies like Veracyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Veracyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Veracyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.